Evercore Wealth Management, LLC Amgen Inc Transaction History

Evercore Wealth Management, LLC

  • $6.66 Billion
  • Q3 2024

A detailed history of Evercore Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Evercore Wealth Management, LLC holds 19,923 shares of AMGN stock, worth $5.87 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
19,923
Previous 19,915 0.04%
Holding current value
$5.87 Million
Previous $6.22 Million 3.17%
% of portfolio
0.1%
Previous 0.1%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$309.38 - $337.38 $2,475 - $2,699
8 Added 0.04%
19,923 $6.42 Million
Q2 2024

Aug 14, 2024
SELL
$262.75 - $319.31 $53,075 - $64,500
-202 Reduced 1.0%
19,915 $6.22 Million
Q1 2024

May 15, 2024
SELL
$268.87 - $324.56 $125,293 - $151,244
-466 Reduced 2.26%
20,117 $5.72 Million
Q4 2023

Feb 14, 2024
SELL
$255.7 - $288.46 $76,198 - $85,961
-298 Reduced 1.43%
20,583 $5.93 Million
Q3 2023

Nov 14, 2023
SELL
$218.65 - $271.46 $101,016 - $125,414
-462 Reduced 2.16%
20,881 $5.61 Million
Q2 2023

Aug 04, 2023
SELL
$214.27 - $253.37 $101,778 - $120,350
-475 Reduced 2.18%
21,343 $4.74 Million
Q1 2023

May 15, 2023
SELL
$225.79 - $275.2 $61,414 - $74,854
-272 Reduced 1.23%
21,818 $5.27 Million
Q4 2022

Feb 14, 2023
BUY
$229.03 - $291.01 $115,660 - $146,960
505 Added 2.34%
22,090 $5.8 Million
Q3 2022

Nov 14, 2022
BUY
$224.46 - $253.15 $17,956 - $20,252
80 Added 0.37%
21,585 $4.87 Million
Q2 2022

Aug 15, 2022
SELL
$230.71 - $256.74 $12,227 - $13,607
-53 Reduced 0.25%
21,505 $5.23 Million
Q1 2022

May 16, 2022
SELL
$219.27 - $242.57 $59,422 - $65,736
-271 Reduced 1.24%
21,558 $5.21 Million
Q4 2021

Feb 14, 2022
SELL
$198.88 - $227.6 $519,275 - $594,263
-2,611 Reduced 10.68%
21,829 $4.91 Million
Q3 2021

Nov 15, 2021
SELL
$212.27 - $248.7 $749,313 - $877,911
-3,530 Reduced 12.62%
24,440 $5.2 Million
Q2 2021

Aug 16, 2021
SELL
$233.58 - $259.14 $108,614 - $120,500
-465 Reduced 1.64%
27,970 $6.82 Million
Q1 2021

May 17, 2021
BUY
$221.91 - $258.6 $8,210 - $9,568
37 Added 0.13%
28,435 $7.08 Million
Q4 2020

Feb 16, 2021
SELL
$216.38 - $257.67 $205,561 - $244,786
-950 Reduced 3.24%
28,398 $6.53 Million
Q3 2020

Nov 16, 2020
SELL
$234.65 - $260.95 $2,581 - $2,870
-11 Reduced 0.04%
29,348 $7.46 Million
Q2 2020

Aug 13, 2020
BUY
$197.81 - $242.74 $10,681 - $13,107
54 Added 0.18%
29,359 $6.92 Million
Q1 2020

May 14, 2020
BUY
$182.24 - $241.7 $76,358 - $101,272
419 Added 1.45%
29,305 $5.94 Million
Q4 2019

Feb 13, 2020
SELL
$189.21 - $243.2 $207,374 - $266,547
-1,096 Reduced 3.66%
28,886 $6.96 Million
Q3 2019

Nov 14, 2019
BUY
$174.11 - $208.62 $727,779 - $872,031
4,180 Added 16.2%
29,982 $5.8 Million
Q2 2019

Aug 13, 2019
BUY
$166.7 - $195.41 $120,023 - $140,695
720 Added 2.87%
25,802 $4.76 Million
Q1 2019

May 14, 2019
BUY
$180.87 - $203.88 $589,817 - $664,852
3,261 Added 14.94%
25,082 $4.77 Million
Q4 2018

Feb 13, 2019
SELL
$178.4 - $208.25 $161,987 - $189,091
-908 Reduced 3.99%
21,821 $4.25 Million
Q3 2018

Nov 13, 2018
SELL
$185.29 - $208.89 $425,981 - $480,238
-2,299 Reduced 9.19%
22,729 $4.71 Million
Q2 2018

Aug 14, 2018
BUY
$166.05 - $186.51 $1.25 Million - $1.4 Million
7,500 Added 42.79%
25,028 $4.62 Million
Q1 2018

May 15, 2018
BUY
$169.43 - $198.0 $575,045 - $672,012
3,394 Added 24.01%
17,528 $2.99 Million
Q4 2017

Feb 13, 2018
SELL
$168.79 - $188.59 $8,439 - $9,429
-50 Reduced 0.35%
14,134 $2.46 Million
Q3 2017

Nov 13, 2017
BUY
$167.29 - $191.0 $2.37 Million - $2.71 Million
14,184
14,184 $2.65 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Evercore Wealth Management, LLC Portfolio

Follow Evercore Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evercore Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evercore Wealth Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email